English中文

Offstream
news



Changes

  1. Brazilian drug regulator Anvisa approves the use of the Sinovac's Coronavac vaccine for children aged between 6 to 11 years.
  2. Brazilian drug regulator Anvisa approves the use of the Sinovac CoronaVac vaccine for children between the ages of 6 and 11 years.

Related